Axsome Therapeutics (AXSM) Reports Q4 Loss Per Share of $0.12

Axsome Therapeutics (NASDAQ: AXSM) reported Q4 EPS of ($0.12), versus ($0.14) reported last year.

For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
• ACRES Commercial Realty says labor dispute is hindering hotel sale